However, GALNT3 expression is also shown to be a negative indicator for disease prognosis in non-small cell lung cancer and colorectal carcinoma [40, 41], including colon carcinoma cells selected for hepatic metastasis [42]. This evidence concerns the gene GALNT3 and non-small cell lung carcinoma.